Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,088,148
+$604,172 QoQ
Shares Held
14,051
+10.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#833
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mission Creek Capital Partners, Inc. holds $22,770,041 across 9 Drug Manufacturers - General names. AMGN ranks #3 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,974 | $9,644,256 | |
| 2 | LLY |
ELI LILLY & Co
|
4,541 | $5,446,612 | |
| 3 | AMGN |
Amgen Inc
This page
|
14,051 | $5,088,148 | |
| 4 | ABBV |
AbbVie Inc.
|
17,933 | $887,331 | |
| 5 | PFE |
Pfizer Inc
|
22,248 | $535,731 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,080 | $395,780 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,542 | $321,156 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,250 | $244,885 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,088,148 | 14,051 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,483,976 | 12,744 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,978,125 | 12,154 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,332,217 | 11,808 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,290,210 | 11,784 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,703,083 | 11,886 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,093,536 | 11,869 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,075,494 | 9,545 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,973,586 | 9,517 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,675,451 | 9,410 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,913,322 | 10,115 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,659,111 | 9,894 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,224,862 | 10,021 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,249,725 | 9,306 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,391,862 | 9,107 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,100,051 | 9,317 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,243,226 | 9,220 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,255,696 | 9,328 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,089,071 | 9,286 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,968,075 | 9,255 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,243,231 | 9,203 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,255,711 | 9,066 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,113,194 | 9,191 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,184,759 | 8,596 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,800,319 | 7,633 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,545,005 | 7,621 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||